Skip to content

Company information lookup

NOVOGEN LIMITED (NRT)

Oncology drug research and development.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
NRT 0.165 -2.94% 0.165 0.170 0.165 0.165 0.165 27,333

NOVOGEN LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code NRT
Securities
Official Listing Date 1 September, 1994
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.novogen.com
Registered Office Address Level 1, 16-20 Edgeworth David Ave, Hornsby, NSW, AUSTRALIA, 2077
Head Office Telephone (02) 9476 0344
Head Office Fax (02) 9476 0388
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 4, 60 CARRINGTON STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Prof. Graham Kelly (Chairman, CEO)
Mr Steven R Coffey (Non Exec. Director)
Dr Peter Gunning (Non Exec. Director)
Mr John P O'Connor (Non Exec. Director)
Mr Iain Ross (Non Exec. Director)
Mr David Gryska (External Advisor)
Company Secretary Mr Lionel Mateo
Principal Activities Oncology drug research and development.

NOVOGEN LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
17/04/2014   Ceasing to be a substantial holder 8 PDF
24/03/2014   Change in substantial holding 5 PDF
20/03/2014   Cleansing notice and & Appendix 3B 14 PDF
19/03/2014   Cleansing notice & Appendix 3B 14 PDF
18/03/2014 asterix Novogen and canTx experimental drug proves effective in vivo 2 PDF
13/03/2014   Novogen to present at Annual Sachs Cancer Bio Forum in NY 1 PDF
11/03/2014   Novogen selected to present at Cavendish Global Health Forum 2 PDF
05/03/2014   Initial Director's Interest Notice 4 PDF
05/03/2014   Final Director's Interest Notice 4 PDF
05/03/2014   Novogen appoints new directors and strategic advisor 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
23 Apr 2014 0.170 3.03% 0.170 0.165 79,000
22 Apr 2014 0.165 0% 0.165 0.160 71,665
17 Apr 2014 0.165 6.45% 0.165 0.160 20,000
16 Apr 2014 0.155 -3.12% 0.160 0.155 734,161
15 Apr 2014 0.160 -3.03% 0.170 0.160 39,005

* Volume of shares shown represents only those shares traded on ASX.

NOVOGEN LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security NRT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security NRT

Warrants & Structured Products

No warrants & Structured Products are available over the security NRT

ASX CFDs

No Contracts For Differences are available over the security NRT